Santen Pharmaceutical Co Ltd
TSE:4536
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Santen Pharmaceutical Co Ltd
TSE:4536
|
JP |
|
Elemental Royalty Corp
NASDAQ:ELE
|
CA |
|
T
|
Tapestry Inc
SWB:COY
|
US |
|
C
|
CNH Industrial NV
F:37C
|
UK |
|
Berkah Prima Perkasa Tbk PT
IDX:BLUE
|
ID |
|
Autoneum Holding AG
F:AN9
|
CH |
|
Timbercreek Financial Corp
F:58O
|
CA |
Intrinsic Value
Is Santen Pharmaceutical Co Ltd undervalued or overvalued?
See the intrinsic value estimate for Santen Pharmaceutical Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Santen Pharmaceutical Co Ltd looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with Santen Pharmaceutical Co Ltd’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Santen Pharmaceutical Does
Santen Pharmaceutical is a Japan-based drug company that focuses almost entirely on eye care. It develops, manufactures, and sells prescription medicines and eye drops for conditions such as glaucoma, dry eye, allergies, infections, and other disorders of the eye. It also sells some over-the-counter eye products and related treatments in selected markets.
- Headquarters
- Japan JP
- Employees
- 3 849
- IPO date
- Nov 4, 1963
Santen Pharmaceutical has no economic moat
Santen Pharmaceutical Co Ltd lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Revenue & Expenses Breakdown
Santen Pharmaceutical Co Ltd
Earnings Waterfall
Santen Pharmaceutical Co Ltd
The intrinsic value for Santen Pharmaceutical Co Ltd (4536) under the Base Case is hidden JPY.
Compared with the current market price of 1 734 JPY, the stock appears hidden.